Skip to content

Study of Surgically-Induced Weight Loss on Pelvic Floor Disorders

A Prospective Cohort Study of the Impact of Surgically-Induced Weight Loss on Pelvic Floor Disorders

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT00884871
Enrollment
100
Registered
2009-04-21
Start date
2007-09-30
Completion date
2009-11-30
Last updated
2009-11-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Pelvic Floor Disorders

Keywords

pelvic floor disorders, weight loss

Brief summary

The specific aim of this study is to evaluate the effect of surgically-induced weight reduction, as achieved by laparoscopic gastric banding or sleeve gastrectomy, on pelvic floor disorders such as stress urinary incontinence, overactive bladder, anal incontinence, and pelvic organ prolapse in severely, morbidly and super-obese women using a prospective, observational study design.

Interventions

PROCEDURELapBand

Prospective observation study of 100 obese women undergoing laparoscopic gastric banding to determine impact of weight loss on pelvic floor disorders

Sponsors

University of California, San Diego
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
FEMALE
Age
21 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

* surgical eligibility met by Center for the Treatment Obesity criteria * morbid obesity (BMI \> 40 kg/m2) or severe obesity (BMI \> 33 kg/m2) in presence of NIH co-morbidities * willing to participate in study, including completion of self-reported questionnaires

Exclusion criteria

* pregnancy or planned pregnancy * recent pregnancy or pelvic surgery * age \< 21 years * known neurologic disease or pelvic pathology

Design outcomes

Primary

MeasureTime frame
Prevalence of pelvic floor disorders ascertained by Epidemiology of Prolapse and Incontinence Questionnaire12 months

Secondary

MeasureTime frame
Weekly incontinence episodes and pad use ascertained by incontinence diary12 months
Quality of life impact ascertained by validated measures (PFIQ, PFDI, FISI, and PGI-I)12 months
Sexual function ascertained by validated measure (PISQ)12 months

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026